Traitement adjuvant du cancer colorectal : l’aspirine, une biothérapie ciblée ?
Crossref DOI link: https://doi.org/10.1007/s10269-014-2463-2
Published Online: 2014-12-12
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sibertin-Blanc, C.
Dahan, L.
Michel, P.
Seitz, J.-F.
Text and Data Mining valid from 2014-12-01
